Adverts

Open Access Articles- Top Results for AL-1095

AL-1095

</th></tr>
AL-1095
File:AL-1095 structure.png
Systematic (IUPAC) name
2-(1-phenyl-1-(p-chlorophenyl)methyl)-3-hydroxyquinuclidine
Clinical data
  • Unscheduled
Identifiers
54549-19-8 7pxN
None
PubChem CID 3041659
ChemSpider 2304906 7pxY
Chemical data
Formula C20H22ClNO
327.139 g/mol
 14pxN (what is this?)  (verify)

AL-1095,[1] developed by Aldrich, is a centrally acting stimulant drug with comparable effects to amphetamine,[2] developed by Bristol in the 1970s.[3]

See also

References

  1. ^ US Patent 3506673 -2-(4'HALO)-BENZHYDRYL-3-QUINUCLIDINOLS
  2. ^ Hedblom, P.; Grinspoon, L. (1975). The Speed Culture: Amphetamine Use and Abuse in America. Cambridge: Harvard University Press. p. 50. ISBN 0-674-83192-6. 
  3. ^ Warawa, E. J.; Mueller, N. J.; Gylys, J. A. (1975). "Quinuclidine Chemistry. 3. β-cis-2-(4'-Chlorobenzhydryl)-3-quinuclidinol, a New Central Nervous System Stimulant. Importance of the Benzhydryl Configuration". Journal of Medicinal Chemistry 18 (1): 71–74. PMID 803245. doi:10.1021/jm00235a016. 


Lua error in package.lua at line 80: module 'Module:Buffer' not found.